Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

AB SCIEX, Phenomenex and Peak Scientific Take Mobile Laboratory Across Europe

Published: Friday, November 09, 2012
Last Updated: Friday, November 09, 2012
Bookmark and Share
Mobile lab will stop at EBF Conference in Barcelona next week to demonstrate LC/MS/MS workflows.

AB SCIEX, Phenomenex and Peak Scientific are taking a mobile laboratory across Europe. The European MASStastic Voyage Tour will provide “open house” opportunities for anyone interested in using mass spectrometry and separation science to solve analytical challenges.

Next week this LC/MS/MS laboratory-on-wheels will be open to visitors outside the site of the EBF Conference, a gathering of pharmaceutical scientists in Barcelona.

The tour will make stops in cities across Europe in the new year, including a special appearance at the Berliner Symposium of mass spectrometry users in Germany on April 9, 2013.

Experts in LC/MS/MS solutions from AB SCIEX, Phenomenex and Peak Scientific are on board the mobile laboratory, available to talk to scientists and lab technicians from industry and academia about a broad array of topics, including drug discovery and development, environmental analysis, and small molecule and peptide quantitation.

Changes in European regulations, along with demands for faster, more accurate results and the emergence of next-generation technologies, are spurring questions about how analytical labs can keep up with the rapid pace of change.

Q&A sessions on board the European MASStastic Voyage are designed to help answer these questions, along with showing fully-functional mass spectrometry equipment in operation.

“Because of the sweeping changes happening in Europe, the interest in advanced LC/MS/MS solutions is expanding quickly across the continent, but not everyone can come to an AB SCIEX event or a major trade show, so we are taking a next-generation lab to them with our European MASStastic Voyage,” said Fedja Bobanovic, Vice President of EMEA Sales & Support, AB SCIEX.

Bobanovic continued, “We will be able to show demos, run samples, talk about the data in depth and give scientists and applied market lab personnel useful tips on how to improve their analyses.”

On board the MASStastic Voyage mobile lab will be recently released laboratory technologies designed specifically for a number of laboratory applications commonly used in European laboratories. This MASStastic Voyage Tour will crisscross Europe during the first half of 2013.

“The European MASStastic Voyage mobile lab tour became a reality because of the overwhelming positive and enthusiastic response from analytical scientists from a similar tour throughout North America earlier this year,” said Michael McGinley, Phenomenex HPLC Product Manager.

McGinley continued, “The mass spectrometry expertise of AB SCIEX along with the separation science expertise of Phenomenex has proved to be a potent combination for solving the most urgent and challenging analytical needs of scientists everywhere. This mobile laboratory allows users to see the latest advances in technology and integrated solutions right at their doorstep.”

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Collaboration to Develop Cannabis Testing Standards
SCIEX workflow solution enables cannabis labs to ensure product safety with robust, cost-effective analytical methods to facilitate routine testing.
Tuesday, September 13, 2016
SCIEX Works with the Francis Crick Institute and the University of Cambridge
New proteomic study to develop advanced resource for precision medicine research by using Microflow SWATH® Acquisition for HT industrialized proteomics.
Wednesday, June 29, 2016
Solutions for Biotherapeutic Characterization
Innovation to speed the routine.
Friday, June 17, 2016
SCIEX, QPS Holdings Collaborate
Agreement aims to advance the hybrid LBA-LCMS workflow for biologics quantification.
Wednesday, April 06, 2016
SCIEX, Children's Medical Research Institute Collaborate
SCIEX industrialized proteomics solutions, using SWATH® Acquisition-based workflows and powered by the OneOmics™ Project, will enable large scale proteome studies to advance cancer research.
Thursday, February 11, 2016
SCIEX, A*STAR’s BTI Launch Collaboration
Agreement aims to boost innovation of protein drugs that target new diseases and are safer for patients.
Wednesday, January 27, 2016
SCIEX, Pressure BioSciences Partner
SCIEX and Pressure BioSciences to offer complete solution for next-generation proteomics, to increase the reproducibility and depth of proteomic analysis.
Wednesday, January 13, 2016
SCIEX, University of Manchester Partner
SWATH® Acquisition-based next-generation proteomics technology promises to make industrial proteomics a reality.
Thursday, October 29, 2015
SCIEX Partners with the Paulovich Lab at Fred Hutchinson Cancer Research Center
Collaboration targets research reproducibility crisis with highly validated multiplex quantitation assays.
Wednesday, September 23, 2015
SCIEX and New Objective Announce Partnership
New nanospray sources to offer maximum sensitivity and robustness for NanoLC-MS.
Tuesday, June 02, 2015
SCIEX and New Objective Partner
Partnership will provide advanced nanospray ionization technologies for next-generation proteomics.
Tuesday, May 26, 2015
SCIEX and Hepregen Announce Co-Marketing Agreement
Alliance establishes SCIEX and Hepregen as a one-stop solution provider for drug metabolism investigators.
Friday, May 22, 2015
Sciex, Hepregen Team up on Metabolite Identification Offering
This recently announced collaboration aims to provide practical solutions for drug metabolism researchers.
Thursday, May 21, 2015
Dr. Gyula Vigh wins Arnold O. Beckman Award
SCIEX sponsored award recognizes outstanding contributions to the field of electrodriven separation techniques.
Thursday, May 07, 2015
SCIEX and Mass Consortium Corporation Announce Exclusive Reseller Agreement
SCIEX to provide customers with XCMSplus software solution for simplified and accelerated metabolomics workflows.
Tuesday, March 31, 2015
Scientific News
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
ALS Study Reveals Role of RNA-Binding Proteins
The findings are a significant step forward in validating RNA-based therapy as a treatment for ALS.
New Compound Shows Promise in Treating Multiple Human Cancers
The research presents a new way to efficiently kill these cancerous cells and holds promise for the treatment of all cancers.
Tumor Markers Reveal Lethality Of Bladder Cancers
Researchers found that detection of certain tumor cells in early stage cancers helps identify high-risk cancers.
Lab-on-a-Chip to Help Detect Cancer
In this podcast, we speak to Gustavo Stolovitsky to learn about his career and the work he is doing at IBM Research.
Using CRISPR to Accelerate Search for HIV Cure
Gene-editing platform makes it easier to create HIV-resistant immune cells.
Nanomedicine Aims to Improve HIV Drug Therapies
New research aims to improve the administration and availability of drug therapies to HIV patients using nanotechnology.
Gene Editing Corrects Sickle Cell Mutation
Researchers demonstrate a potential pathway to developing gene-editing treatments for sickle cell disease.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos